Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Matthew K Ball"'
Autor:
Haidong Dong, Svetomir N Markovic, Aaron S Mansfield, Jacob J Orme, Elizabeth Ann L Enninga, Fabrice Lucien-Matteoni, Heather Dale, Edwin Burgstaler, Susan M Harrington, Matthew K Ball, Sean S Park, Mathew S Block, Yiyi Yan, Roxana S Dronca, Jeffrey L Winters
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss 2 (2020)
Background Trans-acting programmed death-ligand 1 (PD-L1) derives from malignant cells in three known forms. High levels of secreted splice variant PD-L1 (sPD-L1), ADAM10/ADAM17-shed sPD-L1, and PD-L1-positive extracellular vesicles (evPD-L1) each pr
Externí odkaz:
https://doaj.org/article/12cda94bbdc0496a8a76193abb6aa4f3
Autor:
John Huston, Matthew K. Ball, Salomon Cohen-Cohen, Ahmed Helal, Jamie J. Van Gompel, Richard L. Ehman, Ziying Yin
Publikováno v:
J Neurosurg
OBJECTIVE Pituitary adenoma is one of the most common primary intracranial neoplasms. Most of these tumors are soft, but up to 17% may have a firmer consistency. Therefore, knowing the tumor consistency in the preoperative setting could be helpful. M
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e20d1cf3e3aa608d5364ff074acc0043
https://doi.org/10.3171/2021.6.jns204425
https://doi.org/10.3171/2021.6.jns204425
Autor:
Jonathan M. Morris, Aditya Raghunathan, Fredric B. Meyer, Adam J. Wood, Megan C. Kaszuba, Matthew K. Ball
Publikováno v:
Brain Tumor Pathology. 37:22-30
Primary central nervous system lymphomas (PCNSLs) are typically intraparenchymal. A subset of PCNSLs predominantly arises in the ventricles, with minimal parenchymal involvement. We review the clinical, radiological, and pathological features of vent
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::72e24a6d18838567e06a2cb4c01f9724
https://doi.org/10.1007/s10014-019-00354-x
https://doi.org/10.1007/s10014-019-00354-x
Publikováno v:
The American Journal of Case Reports
Patient: Female, 23 Final Diagnosis: Clostridial myonecrosis Symptoms: Diarrhea • fever • muscle pain • sepsis Medication: — Clinical Procedure: — Specialty: Infectious Diseases Objective: Unusual clinical course Background: The overuse of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::58e9da5c7e2222c2e8dafbbb8d70fb75
https://doi.org/10.12659/ajcr.913472
https://doi.org/10.12659/ajcr.913472
Autor:
Ian T. Mark, Jamie J. Van Gompel, Carrie Y. Inwards, Matthew K. Ball, Jonathan M. Morris, Carrie M. Carr
Publikováno v:
Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia. 99
Clival chordomas are classically thought of as locally aggressive tumors of the skull base and differentiate themselves from their benign counterparts by demonstrating moderate to marked contrast enhancement, reported as 95-100% in prior studies. The
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d62ce58912b1f2b028cd69036b7bd67c
https://pubmed.ncbi.nlm.nih.gov/35278932
https://pubmed.ncbi.nlm.nih.gov/35278932
Autor:
Svetomir N. Markovic, Yiyi Yan, Edwin A. Burgstaler, Jacob J. Orme, Matthew K. Ball, Mathew S Block, Aaron S. Mansfield, Roxana S. Dronca, Sean S. Park, Susan M. Harrington, Elizabeth Ann L. Enninga, Fabrice Lucien-Matteoni, Heather Dale, Jeffrey L. Winters, Haidong Dong
Publikováno v:
Journal for Immunotherapy of Cancer
BackgroundTrans-acting programmed death-ligand 1 (PD-L1) derives from malignant cells in three known forms. High levels of secreted splice variant PD-L1 (sPD-L1), ADAM10/ADAM17-shed sPD-L1, and PD-L1-positive extracellular vesicles (evPD-L1) each pre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::523ebbbd3b010443d686d038b6e9d683
https://pubmed.ncbi.nlm.nih.gov/32817395
https://pubmed.ncbi.nlm.nih.gov/32817395
Autor:
Matthew K. Ball, Jose C. Villasboas, Aaron S. Mansfield, Xin Liu, Benjamin J. Madden, Roxana S. Dronca, Bharath Wootla, Jacob J. Orme, M. Cristine Charlesworth, Tiancheng Xie, Yanli Li, Fabrice Lucien, Susan M. Harrington, Haidong Dong, Tariq U. Azam, Khalid Jazieh
Publikováno v:
Oncoimmunology
OncoImmunology, Vol 9, Iss 1 (2020)
OncoImmunology, Vol 9, Iss 1 (2020)
ADAM10 and ADAM17 expression and soluble PD-L1 (sPD-L1) predict poor prognosis in many malignancies, including in patients treated with PD-(L)1 inhibitors. The mechanism of soluble PD-L1 production and its effects are unknown. Here we uncover a novel
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3830d88090205d3747a536ae3e9a2fc7
http://europepmc.org/articles/PMC7185206
http://europepmc.org/articles/PMC7185206
Autor:
John Huston, Jamie J. Van Gompel, Joshua D. Hughes, Matthew K. Ball, Salomon Cohen-Cohen, Ziying Yin
Publikováno v:
30th Annual Meeting North American Skull Base Society.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ecde5d823c49f64ff76314171bb81bc7
https://doi.org/10.1055/s-0040-1702481
https://doi.org/10.1055/s-0040-1702481
Autor:
Michelle L McKenna, Caterina Giannini, Mark E. Jentoft, Daniel H. Lachance, Corinne Praska, Benjamin R. Kipp, Aditya Raghunathan, Cristiane M. Ida, Matthew K. Ball, Robert B. Jenkins, Thomas M. Kollmeyer
Publikováno v:
Neuro-oncology Advances
BackgroundOligodendroglioma is genetically defined by concomitant IDH (IDH1/IDH2) mutation and whole-arm 1p/19q codeletion. Codeletion of 1p/19q traditionally evaluated by fluorescence in situ hybridization (FISH) cannot distinguish partial from whol
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::36b6099b8275e0fa5d984f82a53bda44
https://doi.org/10.1093/noajnl/vdaa109
https://doi.org/10.1093/noajnl/vdaa109
Autor:
Khalid Jazieh, Jacob J. Orme, Haidong Dong, Aaron S. Mansfield, Matthew K. Ball, Xin Liu, Roxana S. Dronca, Tariq U. Azam, Susan M. Harrington, Tiancheng Xie
Publikováno v:
Cancer Immunology Research. 7:A210-A210
Background: Tumor surface PD-L1 (B7-H1) signals through T-cell surface receptor PD-1 to suppress antitumor immunity. PD-1 inhibitors like pembrolizumab block this pathway to prevent tumor escape from immunosurveillance. These PD-1 checkpoint inhibito
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2f3aad1f21defcc5ab3efa93acc0be98
https://doi.org/10.1158/2326-6074.cricimteatiaacr18-a210
https://doi.org/10.1158/2326-6074.cricimteatiaacr18-a210